Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • FAA Urges Airlines, Pilots and Others to Take Key Safety Actions
    FAA Urges Airlines, Pilots and Others to Take Key Safety Actions Aviation
  • Sales Performance Management Market Size, Share And Growth Analysis For 2024-2033
    Sales Performance Management Market Size, Share And Growth Analysis For 2024-2033 World News
  • Firefighting Aircraft Market 2025 Trends: Predicted to Grow at a CAGR of 6.3% from 2023 to 2032, Report
    Firefighting Aircraft Market 2025 Trends: Predicted to Grow at a CAGR of 6.3% from 2023 to 2032, Report Aviation
  • Day 99: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин
    Day 99: war diaries w/ Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Фейгин World News
  • U.S.-Uzbekistan Relations – United States Department of State
    U.S.-Uzbekistan Relations – United States Department of State World News
  • Family Enterprise Canada Tackling the Biggest Challenges Facing Canadian Family Businesses
    Family Enterprise Canada Tackling the Biggest Challenges Facing Canadian Family Businesses Business
  • War Day 229: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 229: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • War Day 289: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 289: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

Posted on March 15, 2023 By NewsEditor
TTC Oncology LLC Signs a Collaboration Agreement With Lantern PharmaTTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

EDINA, Minn., March 15, 2023 (Newswire.com) - TTC Oncology ("TTC" or the "Company") announced the signing of a Collaboration Agreement (the "Agreement") with Lantern Pharma Inc. ("LTRN") to expand the clinical development of the TTC drug candidate TTC-352. The Phase-2 ready candidate, TTC-352, is an orally available small molecule being developed as a treatment for patients with metastatic estrogen receptor-positive ("ER+") breast cancer who have failed two or more prior therapies. TTC-352 is a first-in-class selective human ER partial agonist (ShERPA) that in metastatic disease causes ER to induce breast cancer cell death.

The collaboration will be powered by Lantern's artificial intelligence (AI) platform, RADR®, and its 25+ billion oncology-focused data points, 200+ advanced ML algorithms, as well as its four multi-faceted AI drug discovery and development modules. The initial aims of the collaboration will be to 1) identify biomarker or gene signatures to power potential patient selection for an upcoming TTC-352 Phase 2 clinical trial, 2) further characterize TTC-352's mechanism of action, and 3) discover additional treatment indications for TTC-352.

Breast cancer afflicts approximately 2.1 million women in the U.S. yearly with the majority of these cases being ER+, in which ER promotes tumor growth. Patients with ER+ breast cancer are initially treated with endocrine therapy, which blocks the tumorigenic actions of ER. Unfortunately, almost half of all patients who undergo endocrine therapy develop endocrine-resistant metastatic disease and will need chemotherapy as a last resort. TTC-352 provides an alternative approach without the toxicity associated with chemotherapy. 

Under the terms of the collaboration, Lantern Pharma is receiving an exclusive right to license TTC-352, including any collaboration intellectual property (IP), during an exclusive option period. Additionally, Lantern and TTC will each participate in upfront, milestone, and royalty payments in the event a third party licenses IP resulting from the collaboration. No further financial details were disclosed.

About Lantern Pharma

Lantern Pharma ("LTRN") is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR® AI and machine learning platform to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically-targeted therapeutics. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, Lantern's approach represents the potential to deliver best-in-class outcomes. For more information, please visit the company's website at www.lanternpharma.com.

About TTC Oncology LLC

TTC Oncology is an emerging biotechnology company founded in 2015. TTC Oncology's mission is to develop and bring to market a novel, small-molecule therapy, TTC-352, to address the unmet needs of breast cancer patients. TTC has a license from the University of Illinois at Chicago covering the therapy. https://ttconcology.com/ TTC is currently raising funds to complete Phase II studies. 

Contact Information:
Joe Cunningham
CFO
[email protected]
6129911778


Original Source: TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma

The post TTC Oncology LLC Signs a Collaboration Agreement With Lantern Pharma first appeared on Social Gov.

Business

Post navigation

Previous Post: Diverge Health Launched to Build Upon a Decade of Experience Serving Underserved Patients in New York
Next Post: Augmenta acquired by CNH Industrial

Related Posts

  • Wilson Learning Named to 2023 Training Industry Top 20 Sales Training and Enablement Companies List for the 15th Consecutive Year
    Wilson Learning Named to 2023 Training Industry Top 20 Sales Training and Enablement Companies List for the 15th Consecutive Year Business
  • KALP Launches $GINI on MEXC & BingX, Unveils $GINI 250M Grant Program for RWA & DPI Innovation
    KALP Launches $GINI on MEXC & BingX, Unveils $GINI 250M Grant Program for RWA & DPI Innovation Business
  • Corporate Gifting Platform Loop & Tie Simplifies Sales Process by Empowering Choice With Its New Self-Service Feature
    Corporate Gifting Platform Loop & Tie Simplifies Sales Process by Empowering Choice With Its New Self-Service Feature Business
  • Kelly and Kelly P.C. Announces a New Practice Area Representing Students Facing Disciplinary Actions and Other School Related Offenses
    Kelly and Kelly P.C. Announces a New Practice Area Representing Students Facing Disciplinary Actions and Other School Related Offenses Business
  • CyberUp Receives National Programs Standards Approval for Cybersecurity Apprenticeship Program
    CyberUp Receives National Programs Standards Approval for Cybersecurity Apprenticeship Program Business
  • CHAM Agency Sets New Standards in User Experience
    CHAM Agency Sets New Standards in User Experience Business
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
« Jun    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Pulsar Fusion Confirms Expansion to U.S. with New Texas Office, Signs MOU with Thales Alenia Space, Unveils UK’s Largest Space Testing Facility, and Releases New Mission Video to TitanJuly 3, 2025
  • First National Capital Corporation Releases Groundbreaking Research on ERP Financing Trends & Benchmarks for 2025July 3, 2025
  • Global Leader VAC AERO Establishes First US Facility in Greenville, SCJuly 2, 2025
  • Billboard Charts Dance Diva Fawn Makes the Summer Sizzle with Her New Club Track ‘Miami’July 2, 2025
  • STS Impact Windows, Doors & Roofing Expands Hurricane Protection Services Throughout Boca Raton and South Florida RegionJuly 2, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Los hoteles de lujo dominan las tendencias de 2024 en reuniones empresariales
    Los hoteles de lujo dominan las tendencias de 2024 en reuniones empresariales Business
  • FINTEL Launches Customizable Industry Reports to Support Smarter Business Decisions
    FINTEL Launches Customizable Industry Reports to Support Smarter Business Decisions Business
  • War Day 594: Israel Started a Retribution Operation
    War Day 594: Israel Started a Retribution Operation World News
  • War Day 143: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 143: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • New Guide Released to Streamline Third-Party Due Diligence for Banks & Fintechs
    New Guide Released to Streamline Third-Party Due Diligence for Banks & Fintechs Business
  • Secretary Blinken’s Meeting with Israeli Minister for Strategic Affairs Dermer and National Security Advisor Hanegbi
    Secretary Blinken’s Meeting with Israeli Minister for Strategic Affairs Dermer and National Security Advisor Hanegbi World News
  • Josie Brandon’s “Rain From Heaven” Emerges as the Anthem of Light Following Attempted Assassination of President Trump
    Josie Brandon’s “Rain From Heaven” Emerges as the Anthem of Light Following Attempted Assassination of President Trump World News
  • War Day 112:  war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
    War Day 112: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .